Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Sakamoto J, Teramukai S, Koike A, Saji S, Ohashi Y, Nakazato H. Sakamoto J, et al. Among authors: teramukai s. Cancer. 1996 Jun 1;77(11):2206-12. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2206::AID-CNCR4>3.0.CO;2-N. Cancer. 1996. PMID: 8635085
Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan.
Sakamoto J, Nakazato H, Teramukai S, Ohashi Y, Takahashi Y, Mai M, Toge T, Okura H, Kodaira S, Maetani S, Okajima K, Nomoto K, Hattori T, Inokuchi K. Sakamoto J, et al. Among authors: teramukai s. Surg Oncol. 1996 Jun;5(3):133-9. doi: 10.1016/s0960-7404(96)80013-2. Surg Oncol. 1996. PMID: 8908719
Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Saji S, Sakamoto J, Teramukai S, Kunieda K, Sugiyama Y, Ohashi Y, Nakazato H. Saji S, et al. Among authors: teramukai s. Surg Today. 1999;29(6):504-10. doi: 10.1007/BF02482344. Surg Today. 1999. PMID: 10385364 Clinical Trial.
380 results